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Chronic conditions are the leading cause of growing healthcare spending, disability, and
death in the U.S. In the wake of national health reform, policy makers and healthcare
professionals are becoming increasingly concerned in containing healthcare costs while
improving quality of patient care. A basic policy question is whether the Chronic Disease
Self-Management Program (CDSMP), a widely distributed evidenced-based self-managed
program, can be cost-effective in managing chronic conditions while improving quality of
life. Utilizing data from the National Study of CDSMP, the primary objective of the current
study is to estimate cost-effectiveness of the CDSMP program among individuals with at
least one chronic condition. The second objective is to determine how cost-effectiveness
ratios vary by depression status. EuroQol-5D (EQ-5D) was used to measure health-related
quality of life (HRQOL) of CDSMP participants, which was then converted to quality-
adjusted life years (QALYs) for cost-effectiveness analysis. Participants who completed the
CDSMP program experienced higher EQ-5D scores from baseline to 12-month follow-up
(increased from 0.736 to 0.755; p<0.001).The incremental cost-effectiveness ratio (ICER)
ranges from $83,285 to $31,285 per QALYs, which can be comparable to the common
benchmark of $50,000/QALYs. ICER by baseline depression status indicates that it will
cost more per QALYs gained for those diagnosed with depression based on their Patient
Health Questionnaire-8 score. However, cautions should be taken while considering this
point estimate too literally because the average cost for CDSMP participants was a rough
estimate and based on several simplifying assumptions. Identifying cost-effective strate-
gies that can lower the burden of chronic disease among community-dwelling adults is
critical for decision makers in allocating limited resources. Policy makers and community
organizations can use this information to guide funding decisions and delivery of CDSMP
programs for individuals with multiple chronic health conditions.
Keywords: chronic disease self-management, cost-effectiveness analysis, health-related quality of life, older adults,
EQ-5D and quality-adjusted life years
INTRODUCTION
With the rapid aging of the baby boomer cohort, it is estimated that
one in five Americans will be 65 years or older by 2030 (1). Simul-
taneously, the existence of multiple chronic conditions among
Americans 65 years or older is becoming increasingly prevalent,
with 60–75% of older adults having at least two chronic conditions
(2), many of which are preventable (1). Moreover, the number
of Americans with chronic conditions is projected to increase by
37% by the year 2030 (3). More than 75% of total healthcare costs
are attributable to the treatment of chronic illnesses (3). Further-
more, chronic conditions among older adults are associated with
lower quality of life and increased limitations in activities of daily
living (4–7).
With a mission to promote health and the quality of life in
Americans, the U.S. Department of Health and Human Services’
Center for Disease Control and Prevention (CDC) has supported
population surveillance of health-related quality of life (HRQOL)
(8). HRQOL is a multi-dimensional measure, which is defined as
“perceived physical and mental health over time” (9). It can be
considered as a part of a person’s overall quality of life that is
determined by his or her health status. Because HRQOL addresses
physical and mental health of a large number of individuals, it
can offer current health data that public health agencies need
to assess population health. In light of the growing prevalence
of chronic illness, healthcare burdens, and concerns for pro-
moting population health, service providers and policy makers
are pursuing cost-effective ways to design self-management pro-
grams that can improve the health and well-being of the popu-
lation (10, 11). As healthcare costs continue to rise for treating
chronic diseases, identifying ways to manage the progression of
multiple chronic conditions among older adults is critical and
time-sensitive (12, 13).
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To promote health and the quality of life of community-
dwelling older adults, federal, state, and local stakeholders are
implementing evidence-based initiatives to engage individuals in
managing chronic health conditions while improving health out-
comes (14, 15). One such approach is the implementation of
self-management programs that improve health and quality of
life while simultaneously reducing costly healthcare utilization
(16–20). These self-management programs have the potential to
embrace the triple aim goals of healthcare (better care, improved
patient care experience, and lower cost of care) that will enhance
population health (21).
The Chronic Disease Self-Management Program (CDSMP),
one of the well-studied evidence-based programs, improves health
status and chronic illness symptoms while showing promise for
lowering healthcare spending through the reduction in hospital-
ization (22, 23). Although evidence suggests that CDSMP can
improve health outcomes among patients with chronic diseases
(24–26), little is known about the cost-effectiveness of improv-
ing HRQOL among CDSMP participants. Moreover, program
effectiveness may vary when chronic diseases are accompanied
by depression because individuals with depression are less likely
to complete the self-management education programs than those
without depression (27). Thus, the current study has two goals: (1)
to perform an economic evaluation of the CDSMP by utilizing a
cost-effectiveness analysis of HRQOL among CDSMP participants
from baseline to 6-month and 12-month follow-up; and (2) to
examine how the intervention effectiveness varies for participants
with or without depression at baseline.
MATERIALS AND METHODS
NATIONAL STUDY OF CDSMP AS STUDY BASIS
The current study utilized a change in HRQOL measures at three
time points (baseline, at 6-month, and at 12-month) to examine
the cost-effectiveness of the intervention among middle-aged and
older adults enrolled in the National Study of the Chronic Disease
Self-Management Program (CDSMP). Data were analyzed from
workshops delivered nationwide by 22 licensed sites in 17 states
across the nation from August 2010 to April 2011. CDSMP work-
shops were supported by various federal, state and local sources,
healthcare organizations, and community agencies. The eligibil-
ity criteria and recruitment, intervention delivery, and referral
activities are described elsewhere (22). Sites already licensed to
deliver CDSMP were selected and then agreed to participate in the
National Study, delivering the manualized workshops following
standardized intervention protocols and submitting data for study
purposes. Data were collected in person before the start of the
intervention (baseline) and at 6 and 12 months post-intervention
by mail/phone. Investigators had no role in leader training, work-
shop recruitment, or program implementation. Each CDSMP
delivery site recruited people for workshops in their usual fash-
ion, which included referrals from organizations serving older
adults (e.g., senior centers, healthcare facilities, and social ser-
vice organizations as well as self-referrals from other recruitment
activities including flyers, brochures, and health fairs). The inter-
vention was designed to focus on content areas including (a)
techniques to manage typical responses to chronic health prob-
lems such as frustration, fatigue, pain, and isolation: (b) improving
healthy behavior such as physical exercise for maintaining and
improving strength, flexibility, and endurance; and (c) appropri-
ate use of medications, effective communication with healthcare
professionals (24, 28). For the purpose of this study, participants
with complete information on indicators of HRQOL at baseline,
6-month, and 12-month follow-up were included.
Study sample
As a part of translating this intervention, CDSMP included
1,170 community-dwelling individuals at baseline, 6 months, and
12 months across the nation. A total of 825 (71%) participants
completed 12-month follow-up assessment including HRQOL
measures and approximately 77% (n= 903) participants com-
pleted 6-month follow-up (29). While attrition was minimal for
a community-based translational research study, HRQOL infor-
mation at the 6-month follow-up data was missing for 77 partici-
pants (N = 748 contributed to the final analyses). Few differences
were observed based on data attrition. Participants who com-
pleted follow-up assessments at 6-month and 12-month tended
to be older, and completers of the 6-month assessment were
more likely to be non-Hispanic White (15). Institutional Review
Board approval for the National Study was obtained at Stanford
University and Texas A&M University.
MEASURES
Health-related quality of life measures
In the current study, we focus on the healthy-days measure of
HRQOL because it captures the key concepts of population health
and well-being. This construct is aligned with one of CDSMP’s
main objectives of empowering program participants to bet-
ter manage their chronic conditions and experience a higher
quality of life. Healthy-days measures are important compo-
nents that assess HRQOL. The HRQOL includes a set of four
questions (8):
1. Would you say that in general your health is; Excellent, Very
good, Good, Fair, or Poor?
2. Now thinking about your physical health, which includes physi-
cal illness and injury, for how many days during the past 30 days
was your physical health not good?
3. Now thinking about your mental health, which includes stress,
depression, and problems with emotions, for how many days
during the past 30 days was your mental health not good?
4. During the past 30 days, for about how many days did poor
physical or mental health keep you from doing your usual
activities, such as self-care, work, or recreation?
In the current study, we utilize an “unhealthy days” summary
measure, which is based on the second and third questions, esti-
mates the overall number of days when physical and mental health
was not good. We then calculate the number of days estimated to
be healthy, which is the complement to unhealthy days measure
(total number of “healthy days” limits to maximum of 30 days
as this is the maximum possible value that this measure could
possibly take). These items have been extensively used for eval-
uating program objectives in other studies (8, 30–33) and the
validity of these measures has been confirmed in population based
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samples. Participants responded to each item with the number of
days ranging from 0 to 30.
Cost measures
The average cost per CDSMP participant varies by the number
of enrolled participants per workshop with the estimated per-
participant cost ranging from $219 to $583 (23). In the National
Study of CDSMP, 145 workshops had an average size of 12.7
(±4.18) participants, with the majority of workshops (66.2%)
having between 8 and 16 participants. A detailed description of
the cost measures reported by CDSMP delivery sites appears else-
where (23). Based on extant literature confirmed by experts in
the delivery field, we estimated program costs at $350 per par-
ticipant, assuming an average of 10 participants in each CDSMP
workshop (23). These program costs typically include licensure
costs, trained peer personnel, materials, and any space rental
costs (34). Because the CDSMP was a community-based pro-
gram and goal that this type of self-management program is to
provide evidence regarding resources needed to deliver within
the community, cost data are collected at the aggregate level. In
the case of CDSMP, per-participant costs were aggregated at the
workshop level. Individual-level cost data are less valuable for
the effective implementation of this type of community-based
program.
Other participant-level measures
Participants’ demographic characteristics measured at baseline
included age, gender, race/ethnicity, and number of chronic con-
ditions. Measures and a sample questionnaire can be found in
English and Spanish (35). Depressive symptoms were measured
using the Patient Health Questionnaire (PHQ) (36). Self-rated
items (9 DSM-IV criteria) scored from 0 (not at all) to 3 (nearly
everyday) were added to determine overall PHQ score of study
participants at baseline. A score greater than or equal to 10 was
considered clinically depressed because this cut-off point of 10
has a sensitivity and specificity of 88% in detecting a diagnosis
of major depression in primary care patients (36). The reliability
of the PHQ-9 is high, with a Cronbach’s α of 0.89 and test–retest
reliability of 0.84 (37). We used an eight-item version of the PHQ
(38), which excludes the item that asks patients if they have been
bothered by “thoughts that you would be better off dead or of
hurting yourself in some way.” Scores for the eight-item version of
the PHQ range from 0 to 24, and are highly correlated with scores
on the nine-item version (r = 0.997) (38).
ANALYSIS
HRQOL, EQ-5D, and QALYs
The CDC-derived measure of HRQOL is one of the most com-
monly used outcome measures for evaluating burden of disease
in public health research. However, a single measurement such as
quality-adjusted life year (QALY) is considered as a more useful
measure for cost-effectiveness analyses (38–40). This is because
QALY uses preference-based measures of HRQOL, which uses
summary scores (i.e., utility values) to represent population prefer-
ences for different health states. Because the number of unhealthy
days are not preference-based measures of HRQOL (as asked in the
CDSMP survey), the CDC “healthy days” measures cannot be used
directly in the cost-effectiveness analyses (41). Since the CDSMP
survey did not include preference-based measure of EQ-5D, the
non-preference-based scores of “healthy days” measure was con-
verted to preference-based EuroQol 5D (EQ-5D) utilizing the
method proposed by Jia and Lubetkin (42). The EQ-5D is an
internationally developed preference-based (29, 43) method that
provides a measure of utility scores to calculate QALYs which
is used in cost-effectiveness analyses (44). EQ-5D estimates are
obtained from healthy days by matching the cumulative distribu-
tions of the two HRQOL measures and EQ-5D from Behavioral
Risk Factor Surveillance System and Medical Expenditure Panel
Survey datasets (42). For example, we obtained EQ-5D utility
score corresponding to number of “healthy days” measures in our
sample. Detail description of the estimation method including
underlying assumptions can be found in Jia and Lubetkin (42).
Utility values range from 1 (best possible health state) through 0
(death) (44). We then used EQ-5D scores to calculate QALY for
the calculation of cost-effectiveness ratios.
Estimation of participant specific QALYs was based on parti-
tioning the study period into the number of follow-up assessments
and weighting each time interval by the individual’s utility score
during that period of time (45). It is assumed that changes in util-
ity values are linear over time, which is the most commonly used
method in cost-effectiveness analysis. Individual-level QALYs are
then estimated by applying the area-under the curve approach.
Details of this method can be found elsewhere (42). The general
expression for calculating QALYs using individual data that are
fully observed (i.e., no censoring) can be written as follows (45):
QALY =
∑n
t=0
[
(Q1 + Q t+1)
2
× (Tt+1 + Tt)
T
]
(1)
where, n is the number of utility measurements over the study
period (i.e., 1 year), Qt is the individual utility score (i.e., EQ-5D
score) obtained in the t th measurement, T is the total duration of
study period expressed in terms of total number of time units in a
year (e.g., months), T t is the time period in which the t th measure-
ment takes place (expressed as number of time units in a year). In
our case, n= 2 (i.e., first interval from baseline to 6-month and
second interval from 6-month to 12-month), T= 12 (i.e., number
of months in a year), and three time points as T 0= 0, T 1= 6, and
T 2= 12. For example, in our current study, QALYs are obtained
by substituting mean EQ-5D scores and controlling for baseline
utility (45):
Incremental QALY =∑n
t=0
[
(0.743− 0.736)
2
× 6
12
+ (0.743− 0.736)
2
× 6
12
+ (0.755− 0.743)
2
× 6
12
]
= 0.007 (2)
Cost-effectiveness analysis
The strong need to control healthcare costs for the treatment of
chronic diseases led us to search for interventions that produce
greatest value, based on comparative economic evaluation (46).
Cost-effectiveness analysis (CEA) is a type of economic evalua-
tion method that can be utilized to assess whether money is well
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spent in a particular health promotion program (47). Funding
agencies may continue to support programs on the basis of this
information or may find additional interventions that can produce
the best outcomes with available resources. The most widely used
method for CEA is the incremental cost-effectiveness ratio (ICER),
which compares differences in cost to differences in effectiveness
between two competing interventions and therefore relevant for
policy making decisions. In the absence of a control group, we are
comparing health gains compared to no intervention (i.e., “doing
nothing”). Therefore, in this case, ICER was calculated compared
to baseline and measures the effectiveness of CDSMP in improving
QALYs compared to “doing nothing.”
An important first step of calculating ICER is to quantify its
average cost of a program in order to relate the cost to spe-
cific measures of the program (48). Considering zero cost for
“no intervention,” the numerator of ICER is the average cost and
denominator includes the mean effectiveness of the program (48,
49). In our case, the numerator is the mean program cost spent
per CDSMP participant and denominator is QALYs estimates. The
QALYs is particularly useful in quantifying program effectiveness
and is the most commonly used measure of treatment effectiveness
in CEA literature (50, 51). The ICER for each outcome measure
was calculated by dividing per person CDSMP workshop costs by
the QALYs. Therefore ICER can be indicated as:
ICER=
Average cost spent per CDSMP participant−$0
QALYs gained adjusted for baseline utility score
(3)
RESULTS
Table 1 describes participants’ characteristics at baseline. In total,
1,170 participants completed the baseline assessment. On aver-
age, participants were 65 years old, nearly 83% were female, and
had an average of 13 years of education. Ethno-racial composition
included 55% non-Hispanic white, 16% African American, 22%
Hispanic, and 6.5% others. About 79% reported two or more con-
ditions and 79.1% of participants attended four or more workshop
sessions.
Table 1 | Sample characteristics at baseline (N =1170).
Variables % Mean (SD)
Age (in years) 65.4 (14.3)
Female 82.7
Race/ethnicity –
Non-HispanicWhite 55.2
African American 16.0
Hispanic 22.3
Other 6.5
Workshop completion rate 79.1
Education (1–23) 12.9 (3.8)
At least two chronic conditions 79.0
PHQ-8 depression (0–24) 6.6 (5.5)
Healthy days (0–30) 17.9 (11.5)
EQ-5D (0–1)a 0.736 (0.156)
aIn our sample, EQ-5D value ranges from 0.411 to 0.995.
Table 2 represents summary statistics for healthy days and cor-
responding EQ-5D measures at baseline, 6-month, and 12-month
during the study. Both healthy days (17.9–19.2) and correspond-
ing EQ-5D scores (0.743–0.755) were significantly improved from
baseline to 12-month) period (with a p-value <0.001); however,
no significant improvement was observed for these measures from
baseline to 6-month.
Table 3 presents the similar statistics by baseline depression
status. Changes in mean healthy days and EQ-5D scores were
examined by utilizing paired t -test by baseline depression sta-
tus. On average, participants with depression at baseline reported
lower number of healthy days and their corresponding EQ-5D
scores were also lower than participants who had no depression
at baseline. However, both groups (depression versus no depres-
sion at baseline) showed significant improvement in healthy days
and EQ-5D scores from baseline to the12-month period. These
results indicate that CDSMP improves population health sta-
tus among individuals with multiple chronic conditions through
better disease self-management strategies.
Table 4 shows the cost-effectiveness results for the CDSMP
intervention. Incremental cost-effectiveness ratios (ICER) are cal-
culated for the overall group as well as by baseline depression
status. These ratios explain how much each additional QALYs
gained with CDSMP will cost. Overall, ICER ranges from $83,285
to $31,285 per QALYs gained for participants in the CDSMP
program with the median of $50,000/QALYs. ICER by baseline
depression status indicates that it will cost more per QALYs gained
for those diagnosed with depression based on PHQ-8 score.
DISCUSSION
Prior evidence suggests that CDSMP can significantly improve
health outcomes for individuals with a variety of chronic con-
ditions (21, 24). However, economic efficacy of the CDSMP
on HRQOL is not well known. The current study developed
a preference-based EQ-5D measure of HRQOL from healthy
days to quantify the cost-effectiveness of a CDSMP program for
improving QALYS gained for individuals with multiple chronic
conditions. Although there is no universally acceptable threshold
value for cost-effectiveness ratio (52), costs range from $50,000 to
$75000 per QALYs gained have been considered as an acceptable
value for resources expended (48).
Health-related quality of life is recognized as an important
measure in public health as well as clinical research because it
includes a population-based approach that addresses physical and
mental health of a large number of individuals over time. More-
over, converting non-preference-based measures of HRQOL to
a preference-based measure provides a way to compare the effi-
cacy of CDSMP to other evidenced-based disease management
programs in the literature. As shown in the current study, the eco-
nomic value of CDSMP, as measured in dollars per QALYs gained,
may have far reaching effects when magnified across the U.S. Thus,
finding ways to improve the reach of the CDSMP among espe-
cially vulnerable individuals (e.g., rural, minority, low income) is
a critical path of research for future studies.
Policy makers are interested in finding ways to improve
the health of individuals with multiple chronic conditions as
a significant share of healthcare dollars are attributed to the
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Table 2 | Changes in mean (SD) of healthy days and EQ-5D scores among CDSMP participants during the study period.
HRQOL measures Baseline 6months 12months p-value for the change
Baseline and 6months Baseline and 12months
Healthy days (0–30) 17.9 (11.5) 18.5 (11.4) 19.2 (11.1.) 0.25 <0.001
EQ-5D (0–1) 0.736 (0.156) 0.743 (0.156) 0.755 (0.152) 0.32 <0.001
Table 3 | Changes in mean (SD) of healthy days and EQ-5D scores by depression status at baseline.
HRQOL
measures
Depression at baseline (PHQ-8 ≥10) Difference in scores:
baseline and 6-months
Difference in scores:
baseline and 12-months
Yes No Yes No Yes No
Baseline 6-months 12-months Baseline 6-months 12-months
Healthy days 16.4 (11.5) 17.3 (11.4) 17.9 (11.2) 24.1 (8.8) 24.9 (8.8) 27.2 (6.9) 0.33 0.52 0.01 0.001
EQ-5D 0.721 (0.15) 0.728 (0.15) 0.737 (0.15) 0.825 (0.11) 0.830 (0.13) 0.861 (0.10) 0.29 0.96 0.007 0.005
treatment of chronic medical conditions. Deploying resources
with the goal of population-based health management will facil-
itate efficient allocation of resources in such a way that will
lower overall healthcare cost, and improve quality of care expe-
rience (50). The CDSMP provides a mechanism to deliver cost-
effective evidence-based strategies to those who may benefit
most (e.g., being older and having co-morbid conditions). Poor
quality of life and other mental health concerns has broader
effects than immediate impacts on individuals with chronic
conditions.
LIMITATIONS
This study builds upon an existing translational National Study of
CDSMP, which was not originally designed as an economic cost-
effectiveness study. Hence, several variables typically included in
economic analyses were not present (e.g., a comparison group
or individual cost measures). While there was some participant
attrition over time, the impacts appear minimal in terms of the
diversity of participants in the study.
As an accommodation to available data, our study has assumed
a standard per-participant costs now cited in the CDSMP liter-
ature (23). Although ICER values seem very attractive, cautions
should be used to interpret too literally because these values
can change substantially depending on changes in cost estimates
assumption and point estimates. We acknowledge that this is a
rough estimate that excludes a full consideration of all poten-
tial costs. One consideration is whether to include the oppor-
tunity cost of participating in the CDSMP program. Here, the
opportunity cost would be the value of participation time in
the workshop and which could be calculated based on wage for-
gone or the value of leisure time forgone. Since the majority of
CDSMP participants are older adults, we can make the assump-
tion that there is limited (if any) opportunity cost involved in
terms of forgone wages as they are likely to be out of labor force.
So, the value of leisure time could be the only way to calculate
the opportunity cost of participating in the program. However,
there is evidence that people do not always value the use of
leisure time and it is also hard to estimate the value given the
availability of survey instruments. The theoretical notion is that
high motivation and retirement lower the time cost of partici-
pating in this type of health promotion program. Literature also
suggests excluding time cost of participants in physical activity
interventions (51).
Another limitation is that the calculation of QALYs was not
adjusted for possible confounding factors which could potentially
influence cots and outcome measures (45). Although the use of
multiple regression method would control for this imbalance, the
lack of a control group of CDSMP intervention makes this method
infeasible in the current study. There are many more unmeasured
benefits of the CDSMP that are not captured in the outcomes
presented in the current study. For example, participants typically
report many positive aspects of their participation including new
social interactions. As such, the complete value of this evidence-
based program is not fully measured in the current analysis and
may be targeted for future study.
Using the generally accepted cost-effectiveness ratio of
$50,000/QALYs, results of this study indicate that CDSMP is
potentially cost-effective for individuals with multiple chronic
conditions. Utilizing the most widely used generic measure of
HRQOL from a population-based health days measure, the cur-
rent study quantifies cost-effectiveness of CDSMP. However, due
to the fact that CERs evaluate how a program’s costs compare to
its outcomes, judgments about whether the outcomes achieved are
worth than the cost are subjective and dependent on several factors
(e.g., current needs and resources).
Nevertheless, we feel that this study makes a major contribution
as one of the first studies to quantify the benefits of CDSMP in
terms of a preference-based quality of life measure and examine
the impacts for those with co-morbid depressive symptomatol-
ogy. It provides a foundation for future cost-effectiveness studies
of self-management programs for adults with multiple chronic
conditions.
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